Search for company
Explore more than 1.3 million company profiles from emerging markets

Imexpharm Corporation (Công ty Cổ phần Dược phẩm Imexpharm) (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 44,500.00
Volume 25,110
Turnover 1,098,562,500
Index VN Index
Market Ho Chi Minh City Stock Exchange
Ticker IMP
Market Cap Market Cap 516,316,590
52 Week High 48,900.00
52 Week Low 34,333.34
P/E 6.02
EPS 5637.96
Dividend Yield 1000 (June 28, 2013)
Bookvalue 1,029,538,633
Enterprise Value 337,766,540
Quote updated on May 25, 2015
Note: data in VND Thousands.
Select Items to chart them. 2015 Q1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 1,067,250,110
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: EMIS Company Database.
Company Description

Imexpharm Corporation (IMP) primarily manufactures, exports and imports pharmaceutical products, materials, medical facilities. IMP owns two main factories located in headquarter of Dong Thap province, according to GMP-ASEAN standard, and the system of warehouse according to GLP-ASEAN standard. The main products include painkiller, antipyretic, antibiotic, vitamin, nutrition food. IMP was founded in 2006 and based in Dong Thap, Mekong Delta, Vietnam. The company is listed on Ho Chi Minh Stock Exchange…

Main Products

Pharmaceutical products

Contact Information

No. 4, Road 30/4, Ward 1, Cao Lanh Town, Dong Thap Province
Dong Thap; Mekong River Delta; Map
Tel: +84 (67) 851-620
Fax: +84 (67) 853-106

Full name: Imexpharm Corporation

Previous name(s): Dong Thap Pharmaceutical Joint Stock Company (1999)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 04-Dec-06

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
Key Executives
Ownership Details
Affiliates and related companies
Công ty Cổ phần Hiệp Thành
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Competitors - Vietnam

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.